Filing Details
- Accession Number:
- 0001127602-17-022382
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-29 17:10:30
- Reporting Period:
- 2017-06-28
- Filing Date:
- 2017-06-29
- Accepted Time:
- 2017-06-29 17:10:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1681689 | Bioverativ Inc. | BIVV | Pharmaceutical Preparations (2834) | 813461310 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1696784 | Diantha Duvall | 225 2Nd Avenue Waltham MA 02451 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-06-28 | 818 | $60.47 | 2,128 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
